The self-developed humanized anti-HER2 chimeric antigen receptor macrophage (human anti-HER2 CAR-M) has been developed to use an adenoviral vector system to express CAR molecules, which specifically bind to human HER2 antigens to recognize and kill tumor cells (53, 54). The gene discussed is ERBB2; the disease is neoplasm.